[Effects of a vasopressin-corticoid association in patients having an astrocytoma or cerebral metastasis. Evolutive study using complementary methods].
D000324:Adrenocorticotropic Hormone / Q000378:metabolism / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D001254:Astrocytoma / Q000188:drug therapy / Q000503:physiopathology; D001929:Brain Edema / Q000188:drug therapy; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*; D002533:Cerebral Angiography; D004453:Echoencephalography; D004569:Electroencephalography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010902:Pituitary Gland / Q000503:physiopathology*; D011877:Radionuclide Imaging; D014667:Vasopressins / Q000378:metabolism / Q000627:therapeutic use
D014667:Vasopressins; D000324:Adrenocorticotropic Hormone
Effets d'une association vasopressine-corticoïde chez des malades porteurs d'astrocytome malin ou de méstastases cérébrales.